Fluence Corporation Limited (ASX:FLC) (OTCMKTS:EMFGF) is pleased to unveil its Aspiral(TM) family of decentralized, smart packaged wastewater treatment solutions, based on its innovative Membrane Aerated Biofilm Reactor technology. Fluence MABR is a spirally wound, self-respiring membrane that provides aeration for the wastewater process and functions as the biological reactor.
Brand Protection and Consumer Connection solutions company YPB Group Ltd (ASX:YPB) presents a summary of activities for the quarter ended 31 March 2018.
Brand Protection and Consumer Connection solutions company YPB Group Ltd (ASX:YPB) is pleased to provide further information as to the Token Sale Event the company is considering.
Fluence Corporation Limited (ASX:FLC) (OTCMKTS:EMFGF) is pleased to provide the following quarterly business update to the market alongside its Appendix 4C: Quarterly cashflow report for the three months ended 31 March 2018 (Q1 2018).
The directors present their report for the consolidated entity consisting of Fluence Corporation Limited (ASX:FLC) (OTCMKTS:EMFGF) (formerly Emefcy Group Limited) and the entities it controlled at the end of, or during, the year ended 31 December 2017. Throughout the report, the consolidated entity is referred to as the Group.
Fluence Corporation Ltd (ASX:FLC) (OTCMKTS:EMFGF) will release its first quarter 2018 (Q1 2018) business update on 30 April 2018, alongside the Company's Appendix 4C.
Fluence Corporation Limited (ASX:FLC) (OTCMKTS:EMFGF) announced today that it has received a contract to deliver a water treatment reuse system to its customer Rosenblad Design Group. Fluence's zero liquid discharge solution will utilize ultrafiltration and reverse osmosis equipment to treat brine for reuse.
